Log in to save to my catalogue

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated G...

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated G...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608454

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome

About this item

Full title

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome

Publisher

Canada: CMA Joule Inc

Journal title

Canadian Medical Association journal (CMAJ), 2021-11, Vol.193 (46), p.E1766-E1769

Language

English

Formats

Publication information

Publisher

Canada: CMA Joule Inc

More information

Scope and Contents

Contents

Guillain-Barré syndrome (GBS) is an immunologically mediated, inflammatory, demyelinating polyneuropathy. It is thought to be caused by antibody- and immune cell--mediated (T-cell, macrophage) destruction of the myelin and axonal membranes of peripheral neurons. An event such as infection, use of medication, vaccination or surgery usually precedes...

Alternative Titles

Full title

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608454

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8608454

Other Identifiers

ISSN

0820-3946

E-ISSN

1488-2329

DOI

10.1503/cmaj.210947

How to access this item